纳微科技：已有欧盟国家的药物应用项目，但业务占比还不高

Group 1 - The core viewpoint of the article highlights that the company, 纳微科技, is experiencing rapid growth in its overseas business, particularly in the European Union market, although the current contribution from this region is still low [1]. - The company reported that its international business revenue for the first half of 2025 reached 44.02 million yuan, representing a year-on-year increase of 136% [1]. - The company is enhancing its overseas marketing system, strengthening sales capabilities, and increasing collaborations with strategic partners to drive this growth [1].